Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Two US Patents, Bringing Total to 10 in First Patent Family across US and Australia
The two new patents are related to certain cannabinoid-infused beverage compositions using LXRP’s DehydraTECH technology Globally, LXRP has filed some 50 patent applications as the company expands its IP portfolio; LXRP hopes to receive two more granted patents from Australia by year end, giving it 12 in total LXRP out-licenses its technology, which promotes healthier and faster ingestion; the company seeks accelerated patent application examinations in Australia based on the U.S. patents Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has been granted two new U.S. patents based on cannabinoid-infused beverage compositions using its DehydraTECH ingestion technology platform. The company is…